- Home
- NFBK vs ZVRA Comparison
NFBK vs ZVRA Comparison
Compare NFBK & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NFBK | ZVRA |
|---|---|---|
| Founded | 1887 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 541.7M | 472.9M |
| IPO Year | 2010 | 2015 |
Fundamental Metrics
Financial Performance| Metric | NFBK | ZVRA |
|---|---|---|
| Price | $13.22 | $9.57 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $13.50 | ★ $23.00 |
| AVG Volume (30 Days) | 270.7K | ★ 984.5K |
| Earning Date | 01-01-0001 | 06-12-2026 |
| Dividend Yield | ★ 3.94% | N/A |
| EPS Growth | N/A | ★ 159.21 |
| EPS | 0.02 | ★ 1.35 |
| Revenue | $6,870,000.00 | ★ $106,470,000.00 |
| Revenue This Year | $4.95 | $38.67 |
| Revenue Next Year | $6.32 | $53.63 |
| P/E Ratio | $657.75 | ★ $7.34 |
| Revenue Growth | 6.84 | ★ 350.91 |
| 52 Week Low | $9.40 | $6.19 |
| 52 Week High | $14.05 | $13.16 |
Technical Indicators
Market Signals| Indicator | NFBK | ZVRA |
|---|---|---|
| Relative Strength Index (RSI) | 51.14 | 53.43 |
| Support Level | $11.21 | $8.33 |
| Resistance Level | $13.70 | $10.15 |
| Average True Range (ATR) | 0.19 | 0.50 |
| MACD | -0.06 | 0.04 |
| Stochastic Oscillator | 34.25 | 41.16 |
Price Performance
Historical ComparisonAbout NFBK Northfield Bancorp Inc. (Delaware)
Northfield Bancorp Inc is the holding company for Northfield Bank. Its subsidiary provides banking services to individuals and corporate customers in Richmond and Kings Counties in New York, and Hunterdon, Mercer, Union, and Middlesex counties in New Jersey. The bank attracts deposits and offers credit and other banking services.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.